Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016)
Assembly Biosciences (ASMB) recorded quarterly Non Operating Investment Income of $72090.0 in Q1 2016, up 116.62% quarter-over-quarter from -$433707.0 in Q4 2015.
Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016) Analysis & Trends
Assembly Biosciences' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $72090.0 for Q1 2016.
- In Q1 2016, Non Operating Investment Income changed N/A year-over-year to $72090.0; the TTM figure through Mar 2016 stood at -$749495.0 (changed N/A YoY), while the FY2017 annual figure was -$615000.0, up 46.05% from the prior year.
- Non Operating Investment Income was $72090.0 for Q1 2016 at Assembly Biosciences, up from -$433707.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $72090.0 in Q1 2016 to a low of -$433707.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 72,090.00 |
| Mar 31, 2016 | 72,090.00 |
| Dec 31, 2015 | -433,707.00 |
| Dec 31, 2015 | -433,707.00 |
| Sep 30, 2015 | -253,659.00 |
| Sep 30, 2015 | -253,659.00 |
| Jun 30, 2015 | -134,219.00 |
| Jun 30, 2015 | -134,219.00 |